Nephrology Drugs Market 2025 to 2035
Nephrology Drugs Market 2025 to 2035
Nephrology Drugs Market (By Drug Class: ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), B-Blockers, Calcium Channel Blockers, Loop Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Others; By Route of Administration: Oral, Subcutaneous, Intravenous; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2025
USD 18.68 Bn
Forecast Year, 2035
USD 31.83 Bn
CAGR, 2025 - 2035
5.47%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global nephrology drugs market, valued at USD 18.68B in 2025, is projected to reach USD 31.83B by 2035, expanding at a CAGR of 5.47%, driven by rising kidney disease prevalence and advances in therapeutic treatments.
Nephrology Drugs Market Size Analysis
Nephrology Drugs Market Size By Drug Class 2025 to 2035 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACE Inhibitors | 0.49 | 0.50 | 0.54 | 0.57 | 0.59 | 0.64 | 0.68 | 0.71 | 0.75 | 0.77 | 0.84 |
| Angiotensin Receptor Blockers (ARBs) | 0.49 | 0.52 | 0.53 | 0.57 | 0.58 | 0.63 | 0.68 | 0.73 | 0.78 | 0.82 | 0.88 |
| B-Blockers | 3.04 | 3.22 | 3.46 | 3.56 | 3.83 | 4.01 | 4.18 | 4.32 | 4.64 | 4.90 | 5.10 |
| Calcium Channel Blockers | 1.18 | 1.26 | 1.31 | 1.40 | 1.45 | 1.56 | 1.70 | 1.78 | 1.87 | 1.99 | 2.13 |
| Loop Diuretics | 5.02 | 5.28 | 5.50 | 5.89 | 6.09 | 6.37 | 6.74 | 7.18 | 7.59 | 7.83 | 8.30 |
| Erythropoiesis-Stimulating Agents (ESAs) | 5.13 | 5.40 | 5.81 | 6.23 | 6.65 | 7.00 | 7.37 | 7.68 | 8.02 | 8.55 | 8.90 |
| Phosphate Binders | 2.60 | 2.76 | 2.83 | 2.90 | 3.07 | 3.24 | 3.39 | 3.65 | 3.84 | 4.14 | 4.46 |
| Others | 0.72 | 0.76 | 0.79 | 0.81 | 0.86 | 0.92 | 0.98 | 1.05 | 1.11 | 1.16 | 1.21 |
Nephrology Drugs Market Size By Route of Administration 2025 to 2035 (USD Billion)
| Route of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 1.23 | 1.26 | 1.28 | 1.35 | 1.43 | 1.47 | 1.52 | 1.65 | 1.80 | 1.89 | 2.02 |
| Subcutaneous | 12.03 | 12.83 | 13.63 | 14.42 | 15.17 | 15.93 | 16.80 | 17.57 | 18.48 | 19.64 | 20.67 |
| Intravenous | 5.42 | 5.62 | 5.86 | 6.15 | 6.52 | 6.98 | 7.39 | 7.90 | 8.32 | 8.64 | 9.12 |
Nephrology Drugs Market Size By Distribution Channel 2025 to 2035 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 6.65 | 7.19 | 7.64 | 8.21 | 8.65 | 9.21 | 9.88 | 10.28 | 10.80 | 11.54 | 12.41 |
| Retail Pharmacies | 2.30 | 2.43 | 2.51 | 2.67 | 2.78 | 2.95 | 3.19 | 3.39 | 3.58 | 3.76 | 4.04 |
| Online Pharmacies | 9.72 | 10.08 | 10.63 | 11.03 | 11.69 | 12.22 | 12.64 | 13.45 | 14.22 | 14.87 | 15.36 |
Nephrology Drugs Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 12.64 | 13.39 | 14.09 | 15.06 | 15.74 | 16.52 | 17.32 | 18.21 | 19.05 | 20.15 | 21.35 |
| Europe | 2.23 | 2.31 | 2.44 | 2.47 | 2.65 | 2.78 | 2.98 | 3.21 | 3.51 | 3.66 | 3.79 |
| Asia-Pacific | 0.50 | 0.52 | 0.56 | 0.58 | 0.60 | 0.62 | 0.67 | 0.70 | 0.74 | 0.77 | 0.81 |
| Latin America | 3.11 | 3.27 | 3.46 | 3.57 | 3.88 | 4.18 | 4.46 | 4.68 | 4.97 | 5.23 | 5.51 |
| Middle East and Africa | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 | 0.27 | 0.29 | 0.31 | 0.33 | 0.35 | 0.36 |
Nephrology Drugs Market Size to Reach USD 31.83 Billion by 2035
The global nephrology drugs market size was estimated at USD 18.68 billion in 2025 and is projected to be worth around USD 31.83 billion by 2035,with a CAGR of 5.47%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
